2001
DOI: 10.1038/sj.bmt.1703121
|View full text |Cite
|
Sign up to set email alerts
|

Immune reconstitution and production of intracellular cytokines in T lymphocyte populations following autologous peripheral blood stem cell transplantation

Abstract: Summary:For the better understanding of engraftment properties after autologous peripheral blood stem cell transplantation (PBSCT), hematopoietic recovery, immune reconstitution and functional capacity of cytokine production in different lymphocyte populations were examined. In a prospective study, we examined 24 patients suffering from different malignancies after autologous PBSCT. The examination intervals were 1, 3, 6 and 12 months after PBSCT. T cells, B cells and NK cells were analyzed using flow cytometr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
27
0

Year Published

2002
2002
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(31 citation statements)
references
References 31 publications
4
27
0
Order By: Relevance
“…Our immunophenotypic studies confirm and extend earlier observations on T-cell reconstitution after autologous SCT: (i) a very protracted recovery of CD4 þ Tcells, 9,15,29,30 in particular that of the 'naive' CD4 þ , 45R0 À (ECD45RA þ ) subset; 16,[31][32][33] within the 'primed' CD4 þ , 45R0 þ T-cells, the 'central memory' cells expressing the CD62L and CD27 markers were the slowest to recover; 15,16 (ii) a relatively slow recovery of TCR-gd þ T-cells; (iii) a rapid normalization of CD8 þ T-cell counts; 8,15,[29][30][31]33 (iv) initially, a strong upregulation of HLA-DR expression by TCRab þ T-cells, gradually declining to normal at 12 months; 12,30 and (v) upregulation of the apoptosis marker CD95, in particular by the CD4 þ T-cells. 16,34 With respect to cytokine responses, our observation that the capability of CD4 þ and CD8 þ T-cells to produce IFN-g, IL-2 and TNF-a had reached their normal ranges from 2 months post SCT onwards is consistent with that of others.…”
Section: Discussionsupporting
confidence: 80%
“…Our immunophenotypic studies confirm and extend earlier observations on T-cell reconstitution after autologous SCT: (i) a very protracted recovery of CD4 þ Tcells, 9,15,29,30 in particular that of the 'naive' CD4 þ , 45R0 À (ECD45RA þ ) subset; 16,[31][32][33] within the 'primed' CD4 þ , 45R0 þ T-cells, the 'central memory' cells expressing the CD62L and CD27 markers were the slowest to recover; 15,16 (ii) a relatively slow recovery of TCR-gd þ T-cells; (iii) a rapid normalization of CD8 þ T-cell counts; 8,15,[29][30][31]33 (iv) initially, a strong upregulation of HLA-DR expression by TCRab þ T-cells, gradually declining to normal at 12 months; 12,30 and (v) upregulation of the apoptosis marker CD95, in particular by the CD4 þ T-cells. 16,34 With respect to cytokine responses, our observation that the capability of CD4 þ and CD8 þ T-cells to produce IFN-g, IL-2 and TNF-a had reached their normal ranges from 2 months post SCT onwards is consistent with that of others.…”
Section: Discussionsupporting
confidence: 80%
“…In contrast, B cells show delayed recovery, even after 3 months. 12,16,17 Our finding, that ALC recovery 18 Therefore, the role of humoral immunity against MRD may be minor. The hematological dynamics of PB resemble those of BM as a source of ASCT.…”
Section: Discussionmentioning
confidence: 93%
“…[11][12][13][14][15] Natural killer (NK) cells usually reach a normal value within a month, and dendritic cells (DCs) reach a preconditioning level on day þ 20 and nearly normal levels after day þ 180. In contrast, B cells show delayed recovery, even after 3 months.…”
Section: Discussionmentioning
confidence: 99%
“…[1][2][3][4] In children, only limited data on immune reconstitution after ABMT are available. 5,6 Recently, with the use of CD34+ selection in adult autologous transplant recipients, there has been increased interest in studying post transplant infections.…”
Section: Transplantmentioning
confidence: 99%